Page last updated: 2024-11-02

piracetam and Stroke

piracetam has been researched along with Stroke in 44 studies

Piracetam: A compound suggested to be both a nootropic and a neuroprotective agent.

Stroke: A group of pathological conditions characterized by sudden, non-convulsive loss of neurological function due to BRAIN ISCHEMIA or INTRACRANIAL HEMORRHAGES. Stroke is classified by the type of tissue NECROSIS, such as the anatomic location, vasculature involved, etiology, age of the affected individual, and hemorrhagic vs. non-hemorrhagic nature. (From Adams et al., Principles of Neurology, 6th ed, pp777-810)

Research Excerpts

ExcerptRelevanceReference
"One hundred and twenty-eight patients with poststroke seizures were randomly allocated to treatment with either levetiracetam (LEV) or sustained-release carbamazepine (CBZ) in a multicenter randomized open-label study."9.16Levetiracetam versus carbamazepine in patients with late poststroke seizures: a multicenter prospective randomized open-label study (EpIC Project). ( Bosco, D; Consoli, D; Galati, F; Neri, G; Ottonello, GA; Passarella, B; Perticoni, GF; Plastino, M; Postorino, P; Ricci, S; Toni, D, 2012)
"Twenty-four stroke patients with aphasia were randomly allocated to 2 groups: 12 patients received 2400 mg piracetam twice daily, 12 placebo."9.09Piracetam improves activated blood flow and facilitates rehabilitation of poststroke aphasic patients. ( Heiss, WD; Karbe, H; Kessler, J; Thiel, A, 2000)
"Electroencephalographic and clinical effects of piracetam in post-stroke aphasia were evaluated in a prospective, randomized, double-blind, placebo-controlled trial."9.09Restitution of alpha-topography by piracetam in post-stroke aphasia. ( Heiss, WD; Kessler, J; Mielke, R; Szelies, B, 2001)
"We performed a systematic review and meta-analysis to assess whether piracetam facilitates the rehabilitation of language performance in post-stroke patients."8.93Piracetam for Aphasia in Post-stroke Patients: A Systematic Review and Meta-analysis of Randomized Controlled Trials. ( Chen, Z; Luo, B; Wei, R; Zhang, J, 2016)
"There is some suggestion (but no statistically significant result) of an unfavourable effect of piracetam on early death, but this may have been caused by baseline differences in stroke severity in the trials."8.88Piracetam for acute ischaemic stroke. ( Cantisani, TA; Celani, MG; Ricci, S; Righetti, E, 2012)
" The use of AEDs as a possible neuroprotective strategy in brain ischemia is receiving increasing attention and the antiepileptic drug levetiracetam, a 2S-(2-oxo-1-pyrrolidiny1) butanamide, belonging to the pyrrolidone family, could have a crucial role in regulation of epileptogenesis and neuroprotection."8.87Levetiracetam in brain ischemia: clinical implications in neuroprotection and prevention of post-stroke epilepsy. ( Belcastro, V; Pierguidi, L; Tambasco, N, 2011)
"Piracetam and its derivatives demonstrate neuroprotective efficacy in experimental stroke, but our findings raise concerns about the amount of available data, the quality of the studies and publication bias."8.84A systematic review and meta-analysis of the efficacy of piracetam and piracetam-like compounds in experimental stroke. ( Macleod, MR; Sena, ES; Wheble, PC, 2008)
"There is some suggestion (but no statistically significant result) of an unfavourable effect of piracetam on early death, but this may have been caused by baseline differences in stroke severity in the trials."8.83Piracetam for acute ischaemic stroke. ( Cantisani, AT; Celani, MG; Ricci, S; Righetti, E, 2006)
"There is some suggestion (but no statistically significant result) of an unfavourable effect of piracetam on early death, but this may have been caused by baseline differences in stroke severity in the trials."8.81Piracetam for acute ischaemic stroke. ( Cantisani, AT; Celani, MG; Ricci, S; Righetti, E, 2002)
"We studied whether the administration of piracetam in acute, presumed ischemic stroke affects case fatality and functional outcome."8.80Piracetam in acute stroke: a systematic review. ( Cantisani, TA; Celani, MG; Ricci, S; Righetti, E, 2000)
"Randomised trials comparing piracetam with control, with at least mortality reported and entry to the trial within approximately 48 hours of stroke onset."8.80Piracetam for acute ischaemic stroke. ( Cantisani, AT; Celani, MG; Ricci, S; Righetti, E, 2000)
" In this study, we evaluated the effects of phenobarbital and levetiracetam on PR-QTc intervals in patients with post-stroke seizures."7.80Effects of phenobarbital and levetiracetam on PR and QTc intervals in patients with post-stroke seizure. ( Albertini, G; De Sarro, G; Gallelli, L; Gratteri, S; Iemolo, F; Manes, MT; Mercuri, NB; Quirino, G; Sanzaro, E; Scaglione, F; Siniscalchi, A, 2014)
"Stroke is the most common cause of seizures in the elderly."6.73Levetiracetam monotherapy for late poststroke seizures in the elderly. ( Gomceli, YB; Inan, LE; Kutlu, G; Unal, Y, 2008)
"Piracetam was significantly superior to ASA in the secondary endpoint (P=0."6.69Piracetam versus acetylsalicylic acid in secondary stroke prophylaxis. A double-blind, randomized, parallel group, 2 year follow-up study. ( Evers, S; Fischer, M; Grotemeyer, KH; Husstedt, IW, 2000)
"One hundred and twenty-eight patients with poststroke seizures were randomly allocated to treatment with either levetiracetam (LEV) or sustained-release carbamazepine (CBZ) in a multicenter randomized open-label study."5.16Levetiracetam versus carbamazepine in patients with late poststroke seizures: a multicenter prospective randomized open-label study (EpIC Project). ( Bosco, D; Consoli, D; Galati, F; Neri, G; Ottonello, GA; Passarella, B; Perticoni, GF; Plastino, M; Postorino, P; Ricci, S; Toni, D, 2012)
"Due to too few participants, no conclusions could be drawn regarding the ability of levetiracetam to prevent poststroke seizures."5.15Early treatment after stroke for the prevention of late epileptic seizures: a report on the problems performing a randomised placebo-controlled double-blind trial aimed at anti-epileptogenesis. ( Aldenkamp, AP; de Krom, MC; Lodder, J; van Raak, EP; van Tuijl, JH, 2011)
"Twenty-four stroke patients with aphasia were randomly allocated to 2 groups: 12 patients received 2400 mg piracetam twice daily, 12 placebo."5.09Piracetam improves activated blood flow and facilitates rehabilitation of poststroke aphasic patients. ( Heiss, WD; Karbe, H; Kessler, J; Thiel, A, 2000)
"Electroencephalographic and clinical effects of piracetam in post-stroke aphasia were evaluated in a prospective, randomized, double-blind, placebo-controlled trial."5.09Restitution of alpha-topography by piracetam in post-stroke aphasia. ( Heiss, WD; Kessler, J; Mielke, R; Szelies, B, 2001)
"We performed a systematic review and meta-analysis to assess whether piracetam facilitates the rehabilitation of language performance in post-stroke patients."4.93Piracetam for Aphasia in Post-stroke Patients: A Systematic Review and Meta-analysis of Randomized Controlled Trials. ( Chen, Z; Luo, B; Wei, R; Zhang, J, 2016)
"There is some suggestion (but no statistically significant result) of an unfavourable effect of piracetam on early death, but this may have been caused by baseline differences in stroke severity in the trials."4.88Piracetam for acute ischaemic stroke. ( Cantisani, TA; Celani, MG; Ricci, S; Righetti, E, 2012)
" The use of AEDs as a possible neuroprotective strategy in brain ischemia is receiving increasing attention and the antiepileptic drug levetiracetam, a 2S-(2-oxo-1-pyrrolidiny1) butanamide, belonging to the pyrrolidone family, could have a crucial role in regulation of epileptogenesis and neuroprotection."4.87Levetiracetam in brain ischemia: clinical implications in neuroprotection and prevention of post-stroke epilepsy. ( Belcastro, V; Pierguidi, L; Tambasco, N, 2011)
"Pharmacotherapy of aphasia had been discussed for the last twenty years with first bromocriptine and amphetamine and then serotoninergic, GABAergic and cholinergic agents."4.84Pharmacotherapy of aphasia: myth or reality? ( de Boissezon, X; de Boysson, C; Démonet, JF; Peran, P, 2007)
"Piracetam and its derivatives demonstrate neuroprotective efficacy in experimental stroke, but our findings raise concerns about the amount of available data, the quality of the studies and publication bias."4.84A systematic review and meta-analysis of the efficacy of piracetam and piracetam-like compounds in experimental stroke. ( Macleod, MR; Sena, ES; Wheble, PC, 2008)
"There is some suggestion (but no statistically significant result) of an unfavourable effect of piracetam on early death, but this may have been caused by baseline differences in stroke severity in the trials."4.83Piracetam for acute ischaemic stroke. ( Cantisani, AT; Celani, MG; Ricci, S; Righetti, E, 2006)
"The main conclusion of this review is that drug treatment with piracetam may be effective in the treatment of aphasia after stroke."4.81Pharmacological treatment for aphasia following stroke. ( Enderby, P; Greener, J; Whurr, R, 2001)
"There is some suggestion (but no statistically significant result) of an unfavourable effect of piracetam on early death, but this may have been caused by baseline differences in stroke severity in the trials."4.81Piracetam for acute ischaemic stroke. ( Cantisani, AT; Celani, MG; Ricci, S; Righetti, E, 2002)
"We studied whether the administration of piracetam in acute, presumed ischemic stroke affects case fatality and functional outcome."4.80Piracetam in acute stroke: a systematic review. ( Cantisani, TA; Celani, MG; Ricci, S; Righetti, E, 2000)
"Randomised trials comparing piracetam with control, with at least mortality reported and entry to the trial within approximately 48 hours of stroke onset."4.80Piracetam for acute ischaemic stroke. ( Cantisani, AT; Celani, MG; Ricci, S; Righetti, E, 2000)
" In this study, we evaluated the effects of phenobarbital and levetiracetam on PR-QTc intervals in patients with post-stroke seizures."3.80Effects of phenobarbital and levetiracetam on PR and QTc intervals in patients with post-stroke seizure. ( Albertini, G; De Sarro, G; Gallelli, L; Gratteri, S; Iemolo, F; Manes, MT; Mercuri, NB; Quirino, G; Sanzaro, E; Scaglione, F; Siniscalchi, A, 2014)
"The study aimed at the evaluation of clinical efficacy and safety of the neurotrophic medication omaron, a combination of piracetam and cinnarizin, in the early restoration period of ischemic stroke."3.76[Omaron in the rehabilitation of post stroke outpatients]. ( Chuprina, SE, 2010)
"Efficacy of omaron (a combination of piracetam 400 mg and cinnarizin 25 mg) has been studied 3 months after stroke in 90 post-stroke patients."3.75[Use of omaron in patients with post-stroke cognitive disorders]. ( Belavina, GR; Gusev, VV; Levin, IaI; Markin, SP; Parfenov, VA; Starchina, IuA; Vakhnina, NV, 2009)
"The aim of the present work was to compare the morphological changes occurring at the focus of experimental ischemic stroke treated with agents of the neurotrophic group (alpha-GPC, cerebrolysin), an agent with nootropic properties (piracetam), and a mixed-action agent (vinpocetine)."3.74Changes at the focus of experimental ischemic stroke treated with neuroprotective agents. ( Gaikova, ON; Onishchenko, LS; Yanishevskii, SN, 2008)
"The purpose of this study was to compare the morphological changes in the focus of ischemic stroke under the influence of the drugs of neurotrophic group (alpha-GPC, cerebrolysin), drugs possessing the nootropic properties (piracetam) and those with combined effect (vinpocetin)."3.73[Changes in the focus of experimental ischemic stroke under the influence of neuroprotective drugs]. ( Gaĭkova, ON; Ianishevskiĭ, SN; Onishchenko, LS, 2006)
"We studied 400 patients with ischemic stroke, including 200 patients (the main group), who received 3 courses of phenotropil in the complex rehabilitation treatment in dosage 400 mg/day during 1 year after stroke."2.75[Efficacy of phenotropil in the rehabilitation of stroke patients]. ( Il'iaĭnen, EV; Koval'chuk, IV; Koval'chuk, VV; Melikhova, EV; Skoromets, AA; Stoianova, EG; Vysotskaia, ML, 2010)
"Stroke is the most common cause of seizures in the elderly."2.73Levetiracetam monotherapy for late poststroke seizures in the elderly. ( Gomceli, YB; Inan, LE; Kutlu, G; Unal, Y, 2008)
"Piracetam was significantly superior to ASA in the secondary endpoint (P=0."2.69Piracetam versus acetylsalicylic acid in secondary stroke prophylaxis. A double-blind, randomized, parallel group, 2 year follow-up study. ( Evers, S; Fischer, M; Grotemeyer, KH; Husstedt, IW, 2000)
"Carbamazepine was the most chosen antiepileptic drug for secondary prophylaxis, followed by valproate acid, and levetiracetam."1.48[A nationwide multi-center questionnaire survey on the management and treatment of post-stroke seizure and epilepsy in Japan]. ( Abe, S; Fukuma, K; Higashida, K; Ihara, M; Nagatsuka, K; Okuno, Y; Tanaka, T; Tomari, S; Toyoda, K; Yamagami, H, 2018)
"Perinatal arterial stroke is the most frequent form of cerebral infarction in children."1.46Different response to antiepileptic drugs according to the type of epileptic events in a neonatal ischemia-reperfusion model. ( Auvin, S; Baud, O; Bonnin, P; Charriaut-Marlangue, C; Dupuis, N; Enderlin, J; Leger, PL; Morin, L; Perrotte, G, 2017)
"This was very atypical case of herpes simplex encephalitis characterized by a stroke-like episode, atypical MRI findings, and absence of cerebrospinal fluid pleocytosis."1.46Herpes simplex encephalitis presenting as stroke-like symptoms with atypical MRI findings and lacking cerebrospinal fluid pleocytosis. ( Fujita, N; Oyake, M; Tsuboguchi, S; Umeda, M; Umeda, Y; Wakasugi, T, 2017)
"Cerebral venous thrombosis is a rare entity in pregnancy and the postpartum period, with an incidence of 1:10,000 to 1:25,000."1.37Postpartum cerebral venous thrombosis. ( McCaulley, JA; Pates, JA, 2011)
"Drugs approved and used for treatment of stroke vary from country to country."1.35Publication bias perpetuates use of ineffective drugs in stroke. ( Prasad, K, 2009)
"Stroke is associated with elevation of several proinflammatory cytokines such as tumor necrosis factor alpha (TNF-alpha) and interleukin (IL)-8 that are correlated with central nervous system (CNS) injury."1.34TNF-alpha and IL-8 in acute stroke and the modulation of these cytokines by antiplatelet agents. ( Al-Bahrani, A; Bakhiet, M; Shaath, H; Taha, S, 2007)
"Older patients and patients with brain tumors or strokes were preferentially treated with LEV for prevention and/or management of seizures (all P < or = 0."1.34Levetiracetam use in critically ill patients. ( Meckler, JM; Privitera, MD; Shutter, LA; Szaflarski, JP; Szaflarski, M; Yates, SL, 2007)

Research

Studies (44)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's23 (52.27)29.6817
2010's21 (47.73)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tsuboguchi, S1
Wakasugi, T1
Umeda, Y1
Umeda, M1
Oyake, M1
Fujita, N1
Higashida, K1
Tanaka, T1
Yamagami, H1
Tomari, S1
Fukuma, K1
Okuno, Y1
Abe, S1
Nagatsuka, K1
Toyoda, K1
Ihara, M1
Siniscalchi, A1
Scaglione, F1
Sanzaro, E1
Iemolo, F1
Albertini, G1
Quirino, G1
Manes, MT1
Gratteri, S1
Mercuri, NB1
De Sarro, G1
Gallelli, L1
Janszky, J1
Horvath, R1
Komoly, S1
Waheed, W1
Nathan, MH1
Allen, GB1
Borden, NM1
Babi, MA1
Tandan, R1
Zhang, J1
Wei, R1
Chen, Z1
Luo, B1
Morin, L1
Enderlin, J1
Leger, PL1
Perrotte, G1
Bonnin, P1
Dupuis, N1
Baud, O1
Charriaut-Marlangue, C1
Auvin, S1
Kutlu, G1
Gomceli, YB1
Unal, Y1
Inan, LE1
Gusev, EI1
Bogolepova, AN1
Derev'yannykh, EA1
Bel'skaya, GN1
Knoll, EA1
Krylova, LG1
Popov, DV1
Prasad, K1
Parfenov, VA1
Belavina, GR1
Vakhnina, NV1
Gusev, VV1
Levin, IaI1
Markin, SP1
Starchina, IuA1
Chuprina, SE1
Belcastro, V2
Pierguidi, L1
Tambasco, N1
Güngör, L1
Terzi, M1
Onar, MK1
van Tuijl, JH1
van Raak, EP1
de Krom, MC1
Lodder, J1
Aldenkamp, AP1
Koval'chuk, VV1
Skoromets, AA1
Koval'chuk, IV1
Stoianova, EG1
Vysotskaia, ML1
Melikhova, EV1
Il'iaĭnen, EV1
McCaulley, JA1
Pates, JA1
Robins, A1
Patel, M1
Azim, A1
Fernández-Torrón, R1
Esteve-Belloch, P1
Palma, JA1
Riverol, M1
Iriarte, J1
Jungehulsing, GJ1
Israel, H1
Safar, N1
Taskin, B1
Nolte, CH1
Brunecker, P1
Wernecke, KD1
Villringer, A1
Ricci, S6
Celani, MG5
Cantisani, TA2
Righetti, E5
Magomedova, AKh1
Magomedov, MM1
Magomedova, AM1
Magomaev, MF1
Consoli, D1
Bosco, D1
Postorino, P1
Galati, F1
Plastino, M1
Perticoni, GF1
Ottonello, GA1
Passarella, B1
Neri, G1
Toni, D1
Asadullaev, MM1
Saidvaliev, FS1
Shermukhamedova, FK1
Rizvonov, ZhK1
Vakhabova, NM1
Schmidtke, K1
Cantisani, AT3
Xerri, C1
Zennou-Azougui, Y1
Coq, JO1
de Boissezon, X1
Peran, P1
de Boysson, C1
Démonet, JF1
Al-Bahrani, A1
Taha, S1
Shaath, H1
Bakhiet, M1
Onishchenko, LS2
Gaĭkova, ON2
Ianishevskiĭ, SN1
Chan, S1
Ros, S1
You, KY1
Nhem, S1
Salle, JY1
Dudognon, P1
Daviet, JC1
Szaflarski, JP1
Meckler, JM1
Szaflarski, M1
Shutter, LA1
Privitera, MD1
Yates, SL1
Wheble, PC1
Sena, ES1
Macleod, MR1
Yanishevskii, SN1
Kessler, J2
Thiel, A1
Karbe, H1
Heiss, WD2
Grotemeyer, KH1
Evers, S1
Fischer, M1
Husstedt, IW1
Handschu, R1
Garling, A1
Heuschmann, PU1
Kolominsky-Rabas, PL1
Erbguth, F1
Neundörfer, B1
Szelies, B1
Mielke, R1
Greener, J1
Enderby, P1
Whurr, R1

Clinical Trials (2)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
A Randomized Clinical Trial of tDCS to Remediate Phonological Impairment in Aphasia[NCT06010030]200 participants (Anticipated)Interventional2023-08-25Recruiting
Effects of tDCS in Language Recovery and Reorganization in Chronic Aphasia[NCT04166513]4 participants (Anticipated)Interventional2019-12-01Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

12 reviews available for piracetam and Stroke

ArticleYear
[ZONISAMIDE: FIRST CHOICE AMONG THE FIRST-LINE ANTIEPILEPTIC DRUGS IN FOCAL EPILEPSY].
    Ideggyogyaszati szemle, 2015, May-30, Volume: 68, Issue:5-6

    Topics: Adolescent; Age Factors; Aged; Aged, 80 and over; Anticonvulsants; Carbamazepine; Drug Administratio

2015
Piracetam for Aphasia in Post-stroke Patients: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
    CNS drugs, 2016, Volume: 30, Issue:7

    Topics: Aphasia; Humans; Language Disorders; Piracetam; Randomized Controlled Trials as Topic; Stroke; Treat

2016
[Effectiveness of nootropil in the treatment of patients with cerebral stroke].
    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2008, Volume: 108, Issue:1

    Topics: Humans; Nootropic Agents; Piracetam; Stroke

2008
Levetiracetam in brain ischemia: clinical implications in neuroprotection and prevention of post-stroke epilepsy.
    Brain & development, 2011, Volume: 33, Issue:4

    Topics: Animals; Anticonvulsants; Brain Ischemia; Clinical Trials as Topic; Disease Models, Animal; Epilepsy

2011
Piracetam for acute ischaemic stroke.
    The Cochrane database of systematic reviews, 2012, Sep-12, Issue:9

    Topics: Acute Disease; Brain Ischemia; Fibrinolytic Agents; Humans; Neuroprotective Agents; Piracetam; Rando

2012
Piracetam for acute ischaemic stroke.
    The Cochrane database of systematic reviews, 2002, Issue:4

    Topics: Acute Disease; Brain Ischemia; Humans; Neuroprotective Agents; Piracetam; Stroke

2002
Piracetam for acute ischaemic stroke.
    The Cochrane database of systematic reviews, 2006, Apr-19, Issue:2

    Topics: Acute Disease; Brain Ischemia; Humans; Neuroprotective Agents; Piracetam; Stroke

2006
Pharmacotherapy of aphasia: myth or reality?
    Brain and language, 2007, Volume: 102, Issue:1

    Topics: Amphetamine; Aphasia; Bromocriptine; Cholinesterase Inhibitors; Clinical Trials as Topic; Donepezil;

2007
A systematic review and meta-analysis of the efficacy of piracetam and piracetam-like compounds in experimental stroke.
    Cerebrovascular diseases (Basel, Switzerland), 2008, Volume: 25, Issue:1-2

    Topics: Animals; Disease Models, Animal; Neuroprotective Agents; Piracetam; Stroke

2008
Piracetam for acute ischaemic stroke.
    The Cochrane database of systematic reviews, 2000, Issue:2

    Topics: Brain Ischemia; Humans; Neuroprotective Agents; Piracetam; Stroke

2000
Piracetam in acute stroke: a systematic review.
    Journal of neurology, 2000, Volume: 247, Issue:4

    Topics: Acute Disease; Clinical Trials as Topic; Humans; Piracetam; Stroke; Time Factors; Treatment Outcome

2000
Pharmacological treatment for aphasia following stroke.
    The Cochrane database of systematic reviews, 2001, Issue:4

    Topics: Aphasia; Humans; Neuroprotective Agents; Piracetam; Randomized Controlled Trials as Topic; Stroke

2001
Pharmacological treatment for aphasia following stroke.
    The Cochrane database of systematic reviews, 2001, Issue:4

    Topics: Aphasia; Humans; Neuroprotective Agents; Piracetam; Randomized Controlled Trials as Topic; Stroke

2001
Pharmacological treatment for aphasia following stroke.
    The Cochrane database of systematic reviews, 2001, Issue:4

    Topics: Aphasia; Humans; Neuroprotective Agents; Piracetam; Randomized Controlled Trials as Topic; Stroke

2001
Pharmacological treatment for aphasia following stroke.
    The Cochrane database of systematic reviews, 2001, Issue:4

    Topics: Aphasia; Humans; Neuroprotective Agents; Piracetam; Randomized Controlled Trials as Topic; Stroke

2001

Trials

10 trials available for piracetam and Stroke

ArticleYear
Levetiracetam monotherapy for late poststroke seizures in the elderly.
    Epilepsy & behavior : E&B, 2008, Volume: 13, Issue:3

    Topics: Aged; Anticonvulsants; Drug Evaluation; Epilepsy; Female; Follow-Up Studies; Geriatrics; Humans; Lev

2008
Does long term use of piracetam improve speech disturbances due to ischemic cerebrovascular diseases?
    Brain and language, 2011, Volume: 117, Issue:1

    Topics: Aphasia; Female; Humans; Male; Middle Aged; Neuroprotective Agents; Piracetam; Single-Blind Method;

2011
Early treatment after stroke for the prevention of late epileptic seizures: a report on the problems performing a randomised placebo-controlled double-blind trial aimed at anti-epileptogenesis.
    Seizure, 2011, Volume: 20, Issue:4

    Topics: Aged; Anticonvulsants; Double-Blind Method; Epilepsy; Female; Humans; Levetiracetam; Male; Multicent

2011
[Efficacy of phenotropil in the rehabilitation of stroke patients].
    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2010, Volume: 110, Issue:12 Pt 2

    Topics: Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Piracetam; Recovery of Function; Sever

2010
Levetiracetam in patients with central neuropathic post-stroke pain--a randomized, double-blind, placebo-controlled trial.
    European journal of neurology, 2013, Volume: 20, Issue:2

    Topics: Adult; Aged; Anticonvulsants; Cross-Over Studies; Double-Blind Method; Female; Humans; Levetiracetam

2013
Levetiracetam versus carbamazepine in patients with late poststroke seizures: a multicenter prospective randomized open-label study (EpIC Project).
    Cerebrovascular diseases (Basel, Switzerland), 2012, Volume: 34, Issue:4

    Topics: Activities of Daily Living; Aged; Aged, 80 and over; Anticonvulsants; Carbamazepine; Female; Humans;

2012
[Assessment of multimodal effect of cytoflavin in the acute brain stroke in patients with metabolic syndrome].
    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2012, Volume: 112, Issue:10

    Topics: Administration, Intravenous; Aged; Antioxidants; Drug Combinations; Female; Flavin Mononucleotide; H

2012
Piracetam improves activated blood flow and facilitates rehabilitation of poststroke aphasic patients.
    Stroke, 2000, Volume: 31, Issue:9

    Topics: Adolescent; Adult; Aged; Aphasia; Brain; Cerebrovascular Circulation; Combined Modality Therapy; Dou

2000
Piracetam versus acetylsalicylic acid in secondary stroke prophylaxis. A double-blind, randomized, parallel group, 2 year follow-up study.
    Journal of the neurological sciences, 2000, Dec-01, Volume: 181, Issue:1-2

    Topics: Aspirin; Blood Platelets; Demography; Double-Blind Method; Endpoint Determination; Female; Follow-Up

2000
Restitution of alpha-topography by piracetam in post-stroke aphasia.
    International journal of clinical pharmacology and therapeutics, 2001, Volume: 39, Issue:4

    Topics: Adult; Aged; Analysis of Variance; Aphasia; Brain Mapping; Double-Blind Method; Electroencephalograp

2001

Other Studies

22 other studies available for piracetam and Stroke

ArticleYear
Herpes simplex encephalitis presenting as stroke-like symptoms with atypical MRI findings and lacking cerebrospinal fluid pleocytosis.
    Rinsho shinkeigaku = Clinical neurology, 2017, 07-29, Volume: 57, Issue:7

    Topics: Acyclovir; Aged; Antiviral Agents; Biomarkers; Brain; Clonazepam; DNA, Viral; Drug Therapy, Combinat

2017
[A nationwide multi-center questionnaire survey on the management and treatment of post-stroke seizure and epilepsy in Japan].
    Rinsho shinkeigaku = Clinical neurology, 2018, Apr-25, Volume: 58, Issue:4

    Topics: Anticonvulsants; Carbamazepine; Epilepsy; Female; Humans; Japan; Levetiracetam; Male; Piracetam; Sei

2018
Effects of phenobarbital and levetiracetam on PR and QTc intervals in patients with post-stroke seizure.
    Clinical drug investigation, 2014, Volume: 34, Issue:12

    Topics: Aged; Aged, 80 and over; Anticonvulsants; Female; Humans; Levetiracetam; Long QT Syndrome; Male; Mid

2014
Neurofibromatosis 1-associated panhypopituitarism presenting as hypoglycaemic seizures and stroke-like symptoms.
    BMJ case reports, 2015, Nov-03, Volume: 2015

    Topics: Adult; Anti-Bacterial Agents; Anticonvulsants; Antiviral Agents; Brain Diseases; Cafe-au-Lait Spots;

2015
Different response to antiepileptic drugs according to the type of epileptic events in a neonatal ischemia-reperfusion model.
    Neurobiology of disease, 2017, Volume: 99

    Topics: Animals; Animals, Newborn; Anticonvulsants; Brain; Brain Ischemia; Disease Models, Animal; Epilepsy;

2017
Experience in the use of Actovegin in the treatment of patients with cognitive disorders in the acute period of stroke.
    Neuroscience and behavioral physiology, 2008, Volume: 38, Issue:8

    Topics: Aged; Brain Ischemia; Central Nervous System Stimulants; Cerebral Infarction; Cerebrovascular Circul

2008
Publication bias perpetuates use of ineffective drugs in stroke.
    International journal of stroke : official journal of the International Stroke Society, 2009, Volume: 4, Issue:3

    Topics: Fibrinolytic Agents; Humans; Nadroparin; Nootropic Agents; Piracetam; Publication Bias; Research Des

2009
[Use of omaron in patients with post-stroke cognitive disorders].
    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2009, Volume: 109, Issue:6

    Topics: Administration, Oral; Aged; Cinnarizine; Cognition; Cognition Disorders; Dose-Response Relationship,

2009
[Omaron in the rehabilitation of post stroke outpatients].
    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2010, Volume: 110, Issue:6

    Topics: Calcium Channel Blockers; Cinnarizine; Drug Combinations; Humans; Neuroprotective Agents; Piracetam;

2010
Neuroprotection in post-stroke epilepsy: a realistic goal?
    Seizure, 2011, Volume: 20, Issue:8

    Topics: Anticonvulsants; Epilepsy; Female; Humans; Male; Piracetam; Randomized Controlled Trials as Topic; S

2011
Postpartum cerebral venous thrombosis.
    Obstetrics and gynecology, 2011, Volume: 118, Issue:2 Pt 2

    Topics: Anticoagulants; Anticonvulsants; Brain; Female; Heparin; Humans; Hypertension; Levetiracetam; Magnes

2011
A case of physical and mental adverse drug reactions associated with levetiracetam in post-stroke epilepsy.
    Journal of the American Geriatrics Society, 2012, Volume: 60, Issue:1

    Topics: Aged; Anticonvulsants; Cognition; Disease Progression; Drug-Related Side Effects and Adverse Reactio

2012
[Prolonged hemiplegia as the only symptom of a simple focal nonconvulsive status epilepticus].
    Revista de neurologia, 2012, Aug-16, Volume: 55, Issue:4

    Topics: Anticonvulsants; Bacteriuria; Diagnosis, Differential; Diffusion Magnetic Resonance Imaging; Electro

2012
[The results of the use of levetiracetam (keppra) in post-stroke epilepsy].
    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2012, Volume: 112, Issue:6 Pt 2

    Topics: Aged; Anticonvulsants; Epilepsies, Partial; Female; Humans; Levetiracetam; Male; Middle Aged; Pirace

2012
[Does treatment with piracetam in stroke patients with aphasia make sense?].
    Deutsche medizinische Wochenschrift (1946), 2002, Dec-06, Volume: 127, Issue:49

    Topics: Aphasia; Humans; Neuroprotective Agents; Nootropic Agents; Piracetam; Stroke

2002
Neuroprotective effects on somatotopic maps resulting from piracetam treatment and environmental enrichment after focal cortical injury.
    ILAR journal, 2003, Volume: 44, Issue:2

    Topics: Animals; Brain Mapping; Disease Models, Animal; Electrophysiology; Environment, Controlled; Forelimb

2003
TNF-alpha and IL-8 in acute stroke and the modulation of these cytokines by antiplatelet agents.
    Current neurovascular research, 2007, Volume: 4, Issue:1

    Topics: Acute Disease; Adult; Aged; Aspirin; Brain Ischemia; Cells, Cultured; Clopidogrel; Dipyridamole; Fem

2007
[Changes in the focus of experimental ischemic stroke under the influence of neuroprotective drugs].
    Morfologiia (Saint Petersburg, Russia), 2006, Volume: 130, Issue:6

    Topics: Amino Acids; Animals; Brain; Brain Ischemia; Glycerylphosphorylcholine; Male; Neuroprotective Agents

2006
[The management of stroke in Phnom Penh, Cambodia].
    Bulletin de la Societe de pathologie exotique (1990), 2007, Volume: 100, Issue:1

    Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Aspirin; Brain Ischemia; Calcium Channe

2007
Levetiracetam use in critically ill patients.
    Neurocritical care, 2007, Volume: 7, Issue:2

    Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Anticonvulsants; Brain Diseases; Brain Ne

2007
Changes at the focus of experimental ischemic stroke treated with neuroprotective agents.
    Neuroscience and behavioral physiology, 2008, Volume: 38, Issue:1

    Topics: Amino Acids; Animals; Brain; Brain Ischemia; Glycerylphosphorylcholine; Male; Neuroprotective Agents

2008
Acute stroke management in the local general hospital.
    Stroke, 2001, Volume: 32, Issue:4

    Topics: Diuretics; Echocardiography; Electrocardiography; Germany; Health Resources; Hospitals, Community; H

2001